↓ Skip to main content

Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer

Overview of attention for article published in Gynecologic Oncology, June 2008

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy
1 policy source
patent
2 patents

Readers on

mendeley
33 Mendeley